KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:待检查

Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.

The Editors Of The Lancet

Lancet 407(10548) 2588

PMID42330995
PMCID-
DOI10.1016/S0140-6736(26)01241-9
发表日期2026-06-22
AI 判定该论文不进入自动 KM 提取:Publication is an 'Expression of Concern' about a trial, not the primary trial results report.
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。